Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 161.64% | 89.02% | -59.73% | 5.90% | -50.41% |
| Gross Profit | -161.64% | -89.02% | 59.73% | -5.90% | 50.41% |
| SG&A Expenses | 11.97% | -4.40% | 8.14% | 40.73% | -9.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.24% | 11.34% | -25.54% | 28.17% | -25.66% |
| Operating Income | -51.24% | -11.34% | 25.54% | -28.17% | 25.66% |
| Income Before Tax | -13.34% | -0.31% | 27.63% | -24.51% | 1.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.30% | 0.71% | 31.72% | -24.51% | 1.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.30% | 0.71% | 31.72% | -24.51% | 1.44% |
| EBIT | -51.24% | -11.34% | 25.54% | -28.17% | 25.66% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 81.61% | 85.98% | 89.21% | 82.64% | 79.67% |
| Normalized Basic EPS | 81.27% | 85.84% | 88.56% | 82.64% | 79.67% |
| EPS Diluted | 81.61% | 85.98% | 89.21% | 82.64% | 79.67% |
| Normalized Diluted EPS | 81.27% | 85.84% | 88.56% | 82.64% | 79.67% |
| Average Basic Shares Outstanding | 505.17% | 608.33% | 532.63% | 617.33% | 384.64% |
| Average Diluted Shares Outstanding | 505.17% | 608.33% | 532.63% | 617.33% | 384.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |